Agmatine Sulfate: Benefits, Dosage, Side Effects And Research

Agmatine sulfate is a supplement form of agmatine, a molecule your body makes by removing a carbon dioxide group from the amino acid arginine. In the brain it behaves like a neuromodulator, interacting with NMDA glutamate receptors, imidazoline receptors and alpha-2 adrenergic receptors. That broad profile explains why it is sold for everything from workout “pumps” to mood and nerve pain. The human evidence, however, is thin: one small randomized trial in lumbar disc-related nerve pain, a handful of open-label case series, and a large body of animal research. Clinical studies used about 1.3–3.6 g a day.

Disclosure: nootropic.org/ may earn a commission from qualifying purchases made through links on this page, including as an Amazon Associate. This never affects which products we recommend. Learn more.

What Is Agmatine Sulfate?

Agmatine (1-amino-4-guanidinobutane) is the product of arginine decarboxylation. For decades it was thought to be made only by bacteria, plants and lower organisms, until its synthesis pathway was described in the mammalian brain in 1994. In neurons of the brain and spinal cord, agmatine is packaged into synaptic vesicles and released when neurons fire, and it has its own uptake system and breakdown enzyme (agmatinase). Those features led researchers to classify it as a neuromodulator, though much of that work is from animal studies.^[1]

“Agmatine sulfate” simply means agmatine bound to a sulfate salt for stability. It is the form used in the human studies and in nearly all supplements. Agmatine also occurs in small amounts in fermented foods, but supplement doses are far higher.

How Agmatine Works

Agmatine is unusual because it touches several signaling systems at once. A 2024 pharmacology review describes interactions with:^[2]

• NMDA receptors: Agmatine dampens NMDA-type glutamate signaling. Excess NMDA activity is involved in nerve pain sensitization and is the target of the anesthetic ketamine, which is why researchers have explored agmatine for pain and mood.
• Imidazoline receptors: These receptors help regulate blood pressure and other functions. Drugs such as clonidine act partly through them.
• Alpha-2 adrenergic receptors: These influence norepinephrine release, alertness and blood pressure.
• Nitric oxide and polyamines: A review written by 16 independent research groups describes agmatine’s modulatory action on nitric oxide synthesis and polyamine metabolism, alongside neurotransmitter systems.^[3]

The nitric oxide link is the basis for agmatine’s use in pre-workouts. But in research, agmatine is better described as a modulator of nitric oxide synthase than a simple booster, and none of this has been shown to translate into better workouts in people.

Agmatine Benefits: What The Evidence Shows

Claimed Use	Best Human Evidence	Evidence Rating
Lumbar disc-related nerve pain (sciatica-type)	One randomized, placebo-controlled trial (2.67 g/day, 14 days)	Limited
Painful small fiber neuropathy	One open-label case series of 12 patients	Preliminary
Depression	Three-patient case series; animal studies	Preliminary
Exercise performance, “pumps”	No published human trials found	None
Cognition, focus	No published human trials found	None

Nerve Pain And Sciatica (Evidence: Limited)

The strongest human study is a 2010 trial in people with herniated lumbar disc-associated radiculopathy, the nerve-root pain often called sciatica. It had two parts. First, an open-label dose-escalation study tested 1.335 g, 2.67 g and 3.56 g a day for 10 to 21 days to check safety. Then, in the randomized, double-blind phase, 99 participants were assigned to agmatine sulfate 2.67 g a day or a placebo for 14 days.^[4]

Both groups improved over time, as is common with disc-related pain. The agmatine group improved more: average pain measures fell by 26.7% versus 6.0% with placebo, and quality-of-life scores improved by 70.8% versus 20.0%. No treatment-related adverse events were reported in that phase.^[4]

The limitations matter. Only 31 of 51 people in the agmatine group and 30 of 48 in the placebo group were included in the analysis, so roughly 40% of participants were not analyzed. The treatment period was only two weeks. To our knowledge, this result has not been replicated in a second independent randomized trial.

Small Fiber Neuropathy (Evidence: Preliminary)

In a 2020 open-label case series, 12 patients with painful small fiber neuropathy (most with diabetic neuropathy) took 2.67 g a day of a branded agmatine sulfate for two months; 11 completed it. Average pain intensity fell by about 46%.^[5] With no placebo group, no blinding and only 11 completers, this cannot separate agmatine’s effect from placebo response or natural fluctuation in symptoms.

Depression (Evidence: Preliminary)

Agmatine’s NMDA-blocking action has made it a research interest for depression. Animal studies are extensive, and a 2016 review concluded the preclinical findings justify future clinical trials.^[7] That wording is important: the review was calling for human trials, not summarizing them.

The human data consist of a small pilot report in which three people with major depressive disorder experienced remission while taking agmatine; the report also tested whether another drug reversed the effect, and it had no placebo control.^[6] Three uncontrolled cases are not evidence that agmatine treats depression. Depression is a serious medical condition. Anyone experiencing it should work with a clinician, and nobody should stop or change antidepressant medication to try agmatine.

Exercise, Pumps And Focus (Evidence: None In Humans)

Agmatine sulfate is a common pre-workout ingredient, marketed for vascularity and muscle pumps. We found no published human trials testing agmatine for exercise performance, blood flow during training, or cognitive performance in healthy people. If your goal is training, L-citrulline has human trials (with modest results), and creatine has the strongest evidence of all common sports supplements.

Agmatine Sulfate Dosage

Purpose	Dose	Duration	Study
Safety and dose escalation	1.335 g, 2.67 g and 3.56 g/day	10–21 days per step	Keynan 2010[4]
Lumbar disc-associated radiculopathy	2.67 g/day	14 days	Keynan 2010[4]
Painful small fiber neuropathy	2.67 g/day	2 months	Rosenberg 2020[5]
Long-term safety (single person)	2.67 g/day (6 × 445 mg)	5 years	Gilad 2014[8]

Practical points:

• The clinical studies clustered at about 2.67 g a day.^[4] In the five-year case report, this was taken as three 445 mg capsules in the morning and three in the evening, after meals.^[8]
• That is about 11 capsules of a 250 mg product, which is why many people who follow the studied doses use powder.
• Lower doses are common in practice, but there is no human research showing what, if anything, they do.
• Agmatine is often advised to be taken apart from high-protein meals, but this is based on theory rather than human data, so we cannot recommend it with confidence.

Forms And What To Look For

• Agmatine sulfate is the form in every human study and nearly every product.
• Powder vs capsules: Powder suits gram-level doses; capsules suit smaller, measured amounts.
• Branded forms: The neuropathy studies used a specific branded agmatine sulfate. Generic agmatine sulfate should be chemically identical, but purity varies by supplier.
• Testing: Look for a published certificate of analysis showing identity and purity.
• Pre-workout blends: Agmatine inside a proprietary blend gives you no way to know the dose.

Agmatine Sulfate Side Effects And Safety

Short-term human data suggest agmatine sulfate is reasonably well tolerated. In the dose-escalation study, safety laboratory values stayed within normal ranges, but three participants at the highest dose (3.56 g a day) developed mild-to-moderate diarrhea and mild nausea, which resolved after stopping.^[4] In the depression case series, one person had stomach discomfort and loose stools that resolved within days.^[6]

A case report described one person taking 2.67 g a day for five years with normal lab tests and good general health throughout.^[8] A single case cannot establish long-term safety for the population, so treat it as reassuring but weak evidence.

Overall, there are no large or long-term controlled safety studies. Pregnant or breastfeeding women, children and people with kidney disease should avoid it unless a doctor advises otherwise. For general guidance, see our nootropic side effects guide.

Drug Interactions And Who Should Avoid It

No formal human drug interaction studies exist. Based on agmatine’s receptor targets,^[2] talk with a doctor or pharmacist before using it if you take:

• Blood pressure medications, especially clonidine or other drugs acting on alpha-2 or imidazoline receptors.
• Antidepressants or other psychiatric medications, because agmatine acts on brain signaling systems involved in mood.
• NMDA-acting drugs, such as memantine, ketamine or dextromethorphan.
• Opioid or nerve pain medications, as agmatine has been studied for pain and could add to their effects.

These cautions are theoretical, not documented reactions, but the lack of interaction research is itself a reason for care.

How Agmatine Fits With Other Supplements

• Agmatine vs citrulline: For training, L-citrulline is better supported; it has meta-analyses, even if the effects are modest.
• For nerve discomfort: Palmitoylethanolamide (PEA) has several meta-analyses of randomized pain trials, a much larger evidence base than agmatine’s.
• For mood and stress: Ingredients with more controlled human trials include saffron and ashwagandha.

See our nootropic stacks guide for combinations built around better-studied ingredients.

Where To Buy Agmatine Sulfate

If you decide to try agmatine after reviewing the limited evidence with your doctor, choose a single-ingredient product with published testing. Nootropics Depot sells agmatine sulfate as both 250 mg capsules and powder; read our Nootropics Depot review for their testing approach. On Amazon, buy only from listings marked “Sold by Nootropics Depot.”

Agmatine Sulfate FAQs

What Is Agmatine Sulfate Used For?

It is sold for exercise “pumps,” mood and nerve discomfort. Only nerve pain has controlled human data, from a single small randomized trial.^[4]

Is Agmatine A Nootropic?

It acts on brain receptors, but there are no human trials showing it improves memory, focus or other cognitive measures. Most cognitive claims come from animal studies.^[3]

What Is The Agmatine Sulfate Dosage?

Human studies used 1.3–3.6 g a day, most often 2.67 g.^[4] Lower doses are common in pre-workouts but untested.

What Are Agmatine Sulfate Side Effects?

Diarrhea, nausea and loose stools are the most commonly reported, mainly at the highest doses studied.^[4]

Does Agmatine Increase Nitric Oxide?

It influences nitric oxide synthesis in laboratory research,^[3] but no human study has shown it increases blood flow or pumps during exercise.

Can Agmatine Help Depression?

The evidence is too weak to say. Human data are limited to three uncontrolled cases.^[6] Talk with a clinician about evidence-based treatment.

Is Agmatine Better Than Citrulline Malate?

For exercise, no. Citrulline has multiple human meta-analyses; agmatine has none. You can browse both in our ingredient library.

References

1. Halaris et al. Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs. 2007;21(11):885-900. PubMed
2. Rafi et al. Pharmacological profile of agmatine: an in-depth overview. Neuropeptides. 2024;105:102429. PubMed
3. Piletz et al. Agmatine: clinical applications after 100 years in translation. Drug Discovery Today. 2013;18(17-18):880-893. PubMed
4. Keynan et al. Safety and efficacy of dietary agmatine sulfate in lumbar disc-associated radiculopathy. An open-label, dose-escalating study followed by a randomized, double-blind, placebo-controlled trial. Pain Medicine. 2010;11(3):356-368. PubMed
5. Rosenberg et al. Evidence for dietary agmatine sulfate effectiveness in neuropathies associated with painful small fiber neuropathy. A pilot open-label consecutive case series study. Nutrients. 2020;12(2). PubMed
6. Shopsin et al. The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study. Acta Neuropsychiatrica. 2013;25(2):113-118. PubMed
7. Freitas et al. Agmatine, a potential novel therapeutic strategy for depression. European Neuropsychopharmacology. 2016;26(12):1885-1899. PubMed
8. Gilad et al. Long-term (5 years), high daily dosage of dietary agmatine: evidence of safety: a case report. Journal of Medicinal Food. 2014;17(11):1256-1259. PubMed